Keyphrases
Tetanus
100%
Korean Adults
100%
Adult Subjects
100%
Immunogenicity
100%
Diphtheria Toxoid
100%
Active Comparator
100%
Toxoid Vaccine
100%
Diphtheria
75%
Treatment Group
50%
Vaccination
50%
Placebo
50%
Geometric Mean Titer
50%
Adverse Events
25%
After Injection
25%
Placebo-controlled
25%
Antibody Titer
25%
Randomized Double-blind
25%
Seroprotection
25%
Serious Adverse Events
25%
Phase I Clinical Trial
25%
Adverse Drug Reaction
25%
Anti-tetanus Antibody
25%
Active Placebo
25%
Diphtheria Antibodies
25%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Immunogenicity
100%
Diphtheria Vaccine
100%
Diphtheria Tetanus Toxoid
100%
Intramuscular Injection
100%
Tetanus
75%
Diphtheria
75%
Adverse Event
50%
Clinical Trial
25%
Adverse Drug Reaction
25%
Diphtheria Antibody
25%
Tetanus Antibody
25%
Immunology and Microbiology
Immunogenicity
100%
Diphtheria Vaccine
100%
Diphtheria Tetanus Toxoid
100%
Titer
66%
Antibody Titer
33%
Tetanus Antibody
33%
Diphtheria Antibody
33%
Drug Hypersensitivity
33%